Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,858 | -2,262 | -1,036 | -11,508 | -7,359 |
| Depreciation Amortization | 118 | 78 | 46 | 206 | 160 |
| Other Working Capital | 57 | 76 | 23 | 134 | -77 |
| Other Operating Activity | 113 | -299 | -326 | 3,767 | 1,391 |
| Operating Cash Flow | $-3,571 | $-2,407 | $-1,293 | $-7,401 | $-5,885 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17 | -17 | -17 | -13 | -13 |
| Investing Cash Flow | $-17 | $-17 | $-17 | $-13 | $-13 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,153 | 1,003 | 146 | 7,837 | 7,837 |
| Other Financing Activity | 0 | 0 | 0 | -29 | -29 |
| Financing Cash Flow | $1,153 | $1,003 | $146 | $7,809 | $7,809 |
| Beginning Cash Position | 3,230 | 3,230 | 3,230 | 2,834 | 2,834 |
| End Cash Position | 794 | 1,809 | 2,065 | 3,230 | 4,745 |
| Net Cash Flow | $-2,435 | $-1,421 | $-1,165 | $396 | $1,911 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,571 | -2,407 | -1,293 | -7,401 | -5,885 |
| Capital Expenditure | -17 | -17 | -17 | -16 | -16 |
| Free Cash Flow | -3,588 | -2,424 | -1,310 | -7,417 | -5,901 |